Examples of 'impairment see' in a sentence
Meaning of "impairment see"
The phrase 'impairment see' is not a commonly used phrase in English. However, if interpreted as 'Impairment, see...', it could be a way to direct someone's attention towards understanding the concept of impairment. Impairment refers to a loss or deterioration of physical, mental, or emotional functioning, and 'see' in this context means to comprehend or grasp the understanding of it
How to use "impairment see" in a sentence
Basic
Advanced
impairment see
Efavirenz is contraindicated in patients with severe hepatic impairment see.
Adjust dosage in patients with hepatic impairment see CONTRAINDICATIONS and WARNINGS AND PRECAUTIONS sections.
Dose adjustments are recommended for patients with hepatic impairment see section.
Patients with renal impairment see section 4.4 Fluid retention and cardiac failure.
Rimonabant should not be used in patients with severe renal impairment see section dic.
Hepatic impairment see 5.2 Pharmacokinetic properties.
Doxorubicin should not be administered to patients with severe hepatic impairment see CONTRAINDICATIONS.
Patients with hepatic impairment see section 4.2.
Caution is recommended, particularly in those patients with severe hepatic impairment see section.
Dosage adjustments are necessary in subjects with renal impairment see DOSAGE AND ADMINISTRATION.
No Lamivudine / Zidovudine Teva dosage adjustment necessary, unless patient has renal impairment See Section.
Liver disease resulting in hepatic impairment see section 5.2.
The data comprise pupils with an ocular, aural or psychophysical impairment see 16.
Use in patients with severe hepatic impairment see section 4.2.
Modified-release levodopa / carbidopa should be administered cautiously to patients with severe renal impairment see section 4.2.
See also
The possible symptoms and signs of respiratory impairment see table 1 in.
No dose adjustment is required for darunavir / ritonavir in patients with renal impairment see sections.
Desirudin is contraindicated in severe hepatic impairment see section 4.3.
Simeprevir exposure is significantly increased in patients with severe hepatic impairment see section 5.2.
Caution is advised in case of severe hepatic impairment see section 4.4.
The pharmacokinetics of memantine have been studied in subjects with moderate hepatic impairment see PHARMACOKINETICS.
E factors in patients with severe hepatic impairment see section 4.2.
The statistics in Table 19 cover pupils with a mental, physical, or sensory impairment see I.
Contraindicated in patients with renal impairment see section 4.3.
INVENTED NAME } should be administered with caution in patients with severe liver impairment see 4.2.
Prasugrel must not be used in patients with severe hepatic impairment see section 4.
For dose adjustments for patients with hepatic impairment see Table 2.
A lower starting dose is required in the presence of renal impairment see Table 1 below.
Cholib is contraindicated in moderate to severe renal impairment see section 4.3.
No dosage adjustment is necessary based on renal impairment see section 5.2.
Trizivir is contraindicated in patients with hepatic impairment see section 4.3.
No data are available in subjects with severe renal impairment see section 4.2.
No data are available in patients with severe renal impairment see section 4.2.
The effect of erythromycin is additive to that of renal impairment see section 4.4.
Teriflunomide is contraindicated in patients with severe hepatic impairment see section 4.3.
There have been no studies in patients with hepatic impairment see section 5.2.
Visudyne is contraindicated in patients with severe hepatic impairment see section 4.3.
Twynsta is contraindicated in patients with severe hepatic impairment see section 4.3.
No dose adjustment is required in patients with hepatic impairment see section 5.2.
Efavirenz is contraindicated in patients with severe hepatic impairment see section 4.3.
Kaletra is contraindicated in patients with severe liver impairment see section 4.3.
No dose adjustment is recommended in patients with hepatic impairment see section 5.2.
Pritor is contraindicated in patients with severe hepatic impairment see section 4.3.
Ziagen is contraindicated in patients with severe hepatic impairment see section 4.3.
It is not recommended in patients with severe hepatic impairment see section 5.2.
Rasitrio is contraindicated in patients with severe hepatic impairment see section 4.3.
Kivexa is contraindicated in patients with severe hepatic impairment see section 4.3.
Therapeutic experience is limited in patients with renal impairment see section 4.4.
Atripla is contraindicated in patients with severe hepatic impairment see section 4.3.
There are no data in patients with severe hepatic impairment see section 5.2.
You'll also be interested in:
Examples of using See
Show more
Press or to see the rest of the options
See that the stone is securely fastened
I can not see you back there
Examples of using Impairment
Show more
An impairment test is realized during each closing
You have a neurological impairment called somatoparaphrenia
Impairment testing is done at the individual investment level
